Miochol-E is a brand name of acetylcholine ophthalmic, approved by the FDA in the following formulation(s):
MIOCHOL-E (acetylcholine chloride - for solution; ophthalmic)
Manufacturer: BAUSCH AND LOMB
Approval date: September 22, 1993
Strength(s): 20MG/VIAL [RLD]
Has a generic version of Miochol-E been approved?
No. There is currently no therapeutically equivalent version of Miochol-E available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Miochol-E. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Methods and compositions for stabilizing acetylcholine compositions
Patent 6,261,546
Issued: July 17, 2001
Inventor(s): Tsao; Fu-Pao & Minno; George Edward
Assignee(s): Novartis AG
A pharmaceutical product which includes two-chambers, one having a buffered diluent and the other having acetylcholine. Upon mixing the chamber contents, a buffered efficacious acetylcholine product is prepared for post-surgical ophthlamic injection. Another embodiment of the invention is a method of providing an acetylcholine product which has a substantially consistent final pH without substantial degradation of the acetylcholine. The method involves storing an unbuffered acetylcholine separate from a diluent solution which has been buffered, and mixing prior to use.Patent expiration dates:
- April 29, 2019✓
- April 29, 2019
No comments:
Post a Comment